BioSpace News Archive

Esaote Group: Shareholders’ Meeting approves financial statements as of 31 December 2023

The Shareholders’ Meeting of Esaote S.p.A., met in Genoa, approved the company’s financial statements as of 31.12.2023.

April 24, 2024
·
3 min read
Business

Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update

Chemomab Therapeutics Ltd. announced the company will report its first quarter 2024 financial results and provide a business update on May 9, 2024, at 7:00 am Eastern Time.

April 24, 2024
·
1 min read
Policy

Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

Travere Therapeutics, Inc., and CSL Vifor announced that the European Commission has granted conditional marketing authorization for FILSPARI for the treatment of adults with primary IgA nephropathy with a urine protein excretion ≥1.0 g/day.

April 24, 2024
·
16 min read
Drug Development

Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1

Alkermes plc announced initiation of the Vibrance-1 study, a phase 2 clinical trial evaluating the safety and efficacy of ALKS 2680 compared to placebo in patients with narcolepsy type 1.

April 24, 2024
·
5 min read
Genetown

Thermo Fisher Scientific to Host Investor Day - April 24, 2024

Thermo Fisher Scientific Inc., the world leader in serving science, will hold its 2024 Investor Day on Thursday, September 19, starting at 9:00 a.m. in New York City.

April 24, 2024
·
1 min read
Business

Thermo Fisher Scientific Reports First Quarter 2024 Results

Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the first quarter ended March 30, 2024.

April 24, 2024
·
20 min read
Business

PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024

PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that it will report its first quarter 2024 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, May 8, 2024.

April 24, 2024
·
1 min read
Business

Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024

Chimerix announced that it will host a live conference call and audio webcast on Wednesday, May 1, 2024 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2024, and to provide a business overview.

April 24, 2024
·
1 min read
LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units

LSL PHARMA GROUP INC., a Canadian integrated pharmaceutical company, announced the second and final tranche of its private placement financing of Units for $3.8 million representing the second closing of the upsized $7.5 million non-brokered private placement announced on April 11, 2024.

April 24, 2024
·
5 min read
Business

Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results

Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, reported its financial results for the fiscal year ended December 31, 2023.

April 24, 2024
·
14 min read